Literature DB >> 3198688

Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease.

P A Paganetti1, P Caroni, M E Schwab.   

Abstract

Differentiated oligodendrocytes and central nervous system (CNS) myelin are nonpermissive substrates for neurite growth and for cell attachment and spreading. This property is due to the presence of membrane-bound inhibitory proteins of 35 and 250 kD and is specifically neutralized by monoclonal antibody IN-1 (Caroni, P., and M. E. Schwab. 1988. Neuron. 1:85-96). Using rat optic nerve explants, CNS frozen sections, cultured oligodendrocytes or CNS myelin, we show here that highly invasive CNS tumor line (C6 glioblastoma) was not inhibited by these myelin-associated inhibitory components. Lack of inhibition was due to a specific mechanism as the metalloenzyme blocker 1,10-phenanthroline and two synthetic dipeptides containing metalloprotease-blocking sequences (gly-phe, tyr-tyr) specifically impaired C6 cell spreading on CNS myelin. In the presence of these inhibitors, C6 cells were affected by the IN-1-sensitive inhibitors in the same manner as control cells, e.g., 3T3 fibroblasts or B16 melanomas. Specific blockers of the serine, cysteine, and aspartyl protease classes had no effect. C6 cell spreading on inhibitor-free substrates such as CNS gray matter, peripheral nervous system myelin, glass, or poly-D-lysine was not sensitive to 1,10-phenanthroline. The nonpermissive substrate properties of CNS myelin were strongly reduced by incubation with a plasma membrane fraction prepared from C6 cells. This reduction was sensitive to the same inhibitors of metalloproteases. In our in vitro model for CNS white matter invasion, cell infiltration of optic nerve explants, which occurred with C6 cells but not with 3T3 fibroblasts or B16 melanomas, was impaired by the presence of the metalloprotease blockers. These results suggest that C6 cell infiltrative behavior in CNS white matter in vitro occurs by means of a metalloproteolytic activity, which probably acts on the myelin-associated inhibitory substrates.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198688      PMCID: PMC2115648          DOI: 10.1083/jcb.107.6.2281

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  27 in total

1.  Enhancement of delayed-type hypersensitivity by bestatin, an inhibitor of aminopeptidase B and leucine aminopeptidase.

Authors:  H Umezawa; M Ishizuka; T Aoyagi; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1976-08       Impact factor: 2.649

2.  Proteolytic enzymes in normal and transformed cells.

Authors:  V Mahdavi; R O Hynes
Journal:  Biochim Biophys Acta       Date:  1979-03-07

3.  Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system.

Authors:  I Sommer; M Schachner
Journal:  Dev Biol       Date:  1981-04-30       Impact factor: 3.582

4.  Differentiated rat glial cell strain in tissue culture.

Authors:  P Benda; J Lightbody; G Sato; L Levine; W Sweet
Journal:  Science       Date:  1968-07-26       Impact factor: 47.728

5.  Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter.

Authors:  P Caroni; M E Schwab
Journal:  Neuron       Date:  1988-03       Impact factor: 17.173

6.  A simple and reproducible experimental in vivo glioma model.

Authors:  R N Auer; R F Del Maestro; R Anderson
Journal:  Can J Neurol Sci       Date:  1981-11       Impact factor: 2.104

7.  Rat myoblast fusion requires metalloendoprotease activity.

Authors:  C B Couch; W J Strittmatter
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

8.  Purification of rabbit bone inhibitor of collagenase.

Authors:  T E Cawston; W A Galloway; E Mercer; G Murphy; J J Reynolds
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

9.  Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells.

Authors:  J P Quigley
Journal:  J Cell Biol       Date:  1976-11       Impact factor: 10.539

10.  Synthesis and incorporation of myelin polypeptides into CNS myelin.

Authors:  D R Colman; G Kreibich; A B Frey; D D Sabatini
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

View more
  31 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

Review 2.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

3.  Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform.

Authors:  Badriprasad Ananthanarayanan; Yushan Kim; Sanjay Kumar
Journal:  Biomaterials       Date:  2011-08-05       Impact factor: 12.479

4.  Medulloblastoma displays distinct regional matrix metalloprotease expression.

Authors:  G H Vince; C Herbold; R Klein; J Kühl; T Pietsch; S Franz; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

5.  Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.

Authors:  J H Uhm; N P Dooley; J G Villemure; V W Yong
Journal:  Clin Exp Metastasis       Date:  1996-10       Impact factor: 5.150

Review 6.  Tumoral invasion in the central nervous system.

Authors:  Y A De Clerck; H Shimada; I Gonzalez-Gomez; C Raffel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.

Authors:  T Abe; T Mori; K Kohno; M Seiki; T Hayakawa; H G Welgus; S Hori; M Kuwano
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

8.  Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion.

Authors:  A P Amar; S J DeArmond; D R Spencer; P F Coopersmith; D M Ramos; M L Rosenblum
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture.

Authors:  M Lund-Johansen; K Forsberg; R Bjerkvig; O D Laerum
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Increased levels of plasminogen activator inhibitor-1 (PAI-1) in human brain tumors.

Authors:  J S Rao; A Rayford; R A Morantz; B W Festoff; R Sawaya
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.